Normal view
-
cs.AI, q-bio.NC updates on arXiv.org
-
Memory Bear AI Memory Science Engine for Multimodal Affective Intelligence: A Technical Report
arXiv:2603.22306v1 Announce Type: new Abstract: Affective judgment in real interaction is rarely a purely local prediction problem. Emotional meaning often depends on prior trajectory, accumulated context, and multimodal evidence that may be weak, noisy, or incomplete at the current moment. Although multimodal emotion recognition (MER) has improved the integration of text, speech, and visual signals, many existing systems remain optimized for short-range inference and provide limited support fo
-
cs.AI, q-bio.NC updates on arXiv.org
-
Geometric Mixture-of-Experts with Curvature-Guided Adaptive Routing for Graph Representation Learning
arXiv:2603.22317v1 Announce Type: cross Abstract: Graph-structured data typically exhibits complex topological heterogeneity, making it difficult to model accurately within a single Riemannian manifold. While emerging mixed-curvature methods attempt to capture such diversity, they often rely on implicit, task-driven routing that lacks fundamental geometric grounding. To address this challenge, we propose a Geometric Mixture-of-Experts framework (GeoMoE) that adaptively fuses node representation
Geometric Mixture-of-Experts with Curvature-Guided Adaptive Routing for Graph Representation Learning
-
cs.AI, q-bio.NC updates on arXiv.org
-
An Accurate and Interpretable Framework for Trustworthy Process Monitoring
arXiv:2302.10426v3 Announce Type: replace Abstract: Trustworthy process monitoring seeks to build an accurate and interpretable monitoring framework, which is critical for ensuring the safety of energy conversion plant (ECP) that operates under extreme working conditions such as high pressure and temperature. Contemporary self-attentive models, however, fall short in this domain for two main reasons. First, they rely on step-wise correlations that fail to involve physically meaningful semantics
An Accurate and Interpretable Framework for Trustworthy Process Monitoring
-
Omics in Hepatocellular
-
Comment on "Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma"
Ecotoxicol Environ Saf. 2026 Apr 1;314:120063. doi: 10.1016/j.ecoenv.2026.120063. Epub 2026 Mar 23.NO ABSTRACTPMID:41875554 | DOI:10.1016/j.ecoenv.2026.120063
Comment on "Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma"
Ecotoxicol Environ Saf. 2026 Apr 1;314:120063. doi: 10.1016/j.ecoenv.2026.120063. Epub 2026 Mar 23.
NO ABSTRACT
PMID:41875554 | DOI:10.1016/j.ecoenv.2026.120063
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
Comment on "Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma"
Ecotoxicol Environ Saf. 2026 Mar 23;314:120063. doi: 10.1016/j.ecoenv.2026.120063. Online ahead of print.NO ABSTRACTPMID:41875554 | DOI:10.1016/j.ecoenv.2026.120063
Comment on "Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma"
Ecotoxicol Environ Saf. 2026 Mar 23;314:120063. doi: 10.1016/j.ecoenv.2026.120063. Online ahead of print.
NO ABSTRACT
PMID:41875554 | DOI:10.1016/j.ecoenv.2026.120063
-
(Multiomics OR Omics) AND (Lung OR gastric OR Hepatocellular)
-
NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis
Immunotargets Ther. 2026 Mar 17;15:541852. doi: 10.2147/ITT.S541852. eCollection 2026.ABSTRACTPURPOSE: NUP85 encodes protein components of the Nup107-160 subunit of the nuclear pore complex, belonging to the Nucleoporins (NUPs) family, potentially implicating its role in human cancer. This study aims to elucidate the potential involvement of NUP85 in cancer pathogenesis.METHODS: Leveraging data from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Clinical Proteomic Tumor Analy
NUP85 as a Pan-Cancer Immune Biomarker: Integrated Multi Omics and Functional Analyses Reveal Its Role in Tumor Prognosis
Immunotargets Ther. 2026 Mar 17;15:541852. doi: 10.2147/ITT.S541852. eCollection 2026.
ABSTRACT
PURPOSE: NUP85 encodes protein components of the Nup107-160 subunit of the nuclear pore complex, belonging to the Nucleoporins (NUPs) family, potentially implicating its role in human cancer. This study aims to elucidate the potential involvement of NUP85 in cancer pathogenesis.
METHODS: Leveraging data from The Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Clinical Proteomic Tumor Analysis Consortium (CPTAC), Cancer Cell Line Encyclopedia (CCLE), Human Protein Atlas (HPA), Gene Expression Profiling Interactive Analysis (GEPIA), CellMiner, and GeneMANIA databases, we investigated the role of NUP85 across various tumors. Correlations between NUP85 expression and pathological stage, histological grade, survival, immune infiltration, tumor mutational burden (TMB), microsatellite instability (MSI), drug resistance, DNA methylation, copy number variation (CNV), and single-cell expression were analyzed. Gene functional enrichment analysis was conducted to explore NUP85-associated pathways. Molecular biology experiments including Western blotting, flow cytometry, trans-well migration, and invasion assays were performed to validate NUP85's oncogenic role in lung adenocarcinoma (LUAD) and oral squamous cell carcinoma (OSCC) cell lines.
RESULTS: Our findings reveal up-regulated expression of NUP85 in most tumor tissues, with significant correlations observed with pathological stage, survival, immune infiltration, TMB, MSI, drug resistance, DNA methylation, and CNV. Molecular biology experiments confirm NUP85's tumor-promoting role in LUAD and OSCC cell lines. Single-cell sequencing data suggest elevated NUP85 expression primarily in proliferative T cells (Tprolif).
CONCLUSION: NUP85 emerges as a potential tumor marker associated with tumor immunity and poor prognosis. These insights offer avenues for the development of novel therapeutic targets and anti-neoplastic drugs.
PMID:41869435 | PMC:PMC13005628 | DOI:10.2147/ITT.S541852